坦桑尼亚的抗微生物药物的全国消费:2020-2022年
Siana Mapunjo1, Romuald Mbwasi2, Emmanuel Alphonce Nkiligi3
1National Institute for Medical Research, 3 Barack Obama Drive, P.O. Box 9653, Dar es Salaam 11101, Tanzania.
JAC-antimicrobial resistance
|March 6, 2025
概括
坦桑尼亚的抗菌药物消费量增加,特别是像阿齐思罗米这样的宏类药物,这是由于COVID-19期间的不适当使用导致的. 迫切需要管理管理私营部门使用的增加.
科学领域:
- 制药科学 制药科学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 全球抗微生物耐药性领导人小组 (AMR) 敦促各国分享抗微生物消费 (AMC) 和AMR监测数据.
- 在高负担国家,促进获得基本抗微生物药物的机会至关重要.
研究的目的:
- 分析2020-2022年国家一级的AMC数据.
- 确定抗微生物药物使用模式的新兴趋势.
主要方法:
- 数据来源于坦桑尼亚药品和医疗器械管理局,坦桑尼亚医疗商店部门和当地制造商.
- 对每1000名居民 (DID) 的每日定义剂量 (DDD) 的抗微生物消费量进行分析.
主要成果:
- 平均AMC为38.27±5.17 DID. 时间段.
- 在2021-2022年期间,由阿齐思罗米推动的宏类消费量几乎翻了三倍,这与COVID-19大流行有关.
- 私营部门的AMC份额波动,但仍然很大 (66.82%-84.02%).
- 进入类别的抗微生物药物达到世卫组织的目标,而观察类别的消费量增加.
结论:
- 越来越多的私营部门 AMC 需要紧急的抗菌药物管理目标.
- 建议对访问,观察和储备类别进行例行报告.
更多相关视频
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
12.8K
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
6.2K
相关概念视频
00:57Antibiotic Selection
52.1K
Overview
52.1K
01:28Pulmonary Tuberculosis V
162
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
162